RU2004133025A - Препаративные формы, полезные при лечении мужской и женской импотенции - Google Patents

Препаративные формы, полезные при лечении мужской и женской импотенции Download PDF

Info

Publication number
RU2004133025A
RU2004133025A RU2004133025/15A RU2004133025A RU2004133025A RU 2004133025 A RU2004133025 A RU 2004133025A RU 2004133025/15 A RU2004133025/15 A RU 2004133025/15A RU 2004133025 A RU2004133025 A RU 2004133025A RU 2004133025 A RU2004133025 A RU 2004133025A
Authority
RU
Russia
Prior art keywords
treatment
extracts
arginine
male
tribulus terrestris
Prior art date
Application number
RU2004133025/15A
Other languages
English (en)
Other versions
RU2313358C2 (ru
Inventor
Эцио БОМБАРДЕЛЛИ (IT)
Эцио БОМБАРДЕЛЛИ
Паоло МОРАЦЦОНИ (IT)
Паоло МОРАЦЦОНИ
Антонелла РИВА (IT)
Антонелла РИВА
Роберто СЕГИДЗИ (IT)
Роберто СЕГИДЗИ
Original Assignee
Индена С.П.А. (It)
Индена С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Индена С.П.А. (It), Индена С.П.А. filed Critical Индена С.П.А. (It)
Publication of RU2004133025A publication Critical patent/RU2004133025A/ru
Application granted granted Critical
Publication of RU2313358C2 publication Critical patent/RU2313358C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/11Aldehydes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/29Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
    • A61K36/296Epimedium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Claims (8)

1. Фармацевтическая композиция, включающая экстракты Tribulus terrestris, Epimedium koreanum и Cinnamon cassia в весовом соотношении 1,5-3,5:1-2:0,1-0,4 соответственно; и необязательно аргинин или физиологически эквивалентный эфир, его соль или предшественник и подходящий носитель или наполнитель.
2. Композиция по п. 1, в которой весовое соотношение экстрактов Tribulus terrestris, Epimedium koreanum и Cinnamon cassia составляет 2,5:1,5:0,2.
3. Композиция по п. 1 или 2, содержащая экстракты Tribulus terrestris, Epimedium koreanum, Cinnamon cassia и L-аргинин или гидрохлорид L-аргинина соответственно в весовых соотношениях 1,5-3,5:1-2:0,1-0,4:0,5-1,5.
4. Композиция по п. 3, в которой весовое соотношение экстрактов Tribulus terrestris, Epimedium koreanum и Cinnamon cassia и L-аргинина или гидрохлорида L-аргинина составляет 2,5:1,5:0,2:1.
5. Применение экстрактов Tribulus terrestris, Epimedium koreanum и Cinnamon cassia в весовом соотношении 1,5-3,5:1-2:0,1-0,4, соответственно, и необязательно аргинина или физиологически эквивалентных эфиров, его солей или предшественников, для получения лекарственного средства для лечения мужских и женских сексуальных дисфункций.
6. Применение по п. 5 для лечения импотенции, эректильной дисфункции, нарушений либидо, фригидности и аноргазмии.
7. Фармацевтическая композиция, включающая эффективное количество диосцина, икарина и коричного альдегида и подходящий носитель или среду для лекарства.
8. Применение диосцина, икарина и коричного альдегида для получения лекарственного средства для лечения мужских и женских сексуальных дисфункций.
RU2004133025/15A 2002-05-10 2003-05-02 Препаративные формы, полезные при лечении мужской и женской импотенции RU2313358C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002MI000994A ITMI20020994A1 (it) 2002-05-10 2002-05-10 Formulazioni utili nel trattamento dell'impotenza maschile e femminile
ITMI2002A000994 2002-05-10

Publications (2)

Publication Number Publication Date
RU2004133025A true RU2004133025A (ru) 2005-04-20
RU2313358C2 RU2313358C2 (ru) 2007-12-27

Family

ID=11449870

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2004133025/15A RU2313358C2 (ru) 2002-05-10 2003-05-02 Препаративные формы, полезные при лечении мужской и женской импотенции

Country Status (20)

Country Link
US (2) US7361370B2 (ru)
EP (2) EP1505997B1 (ru)
JP (2) JP4733385B2 (ru)
KR (1) KR20040102219A (ru)
CN (1) CN100522178C (ru)
AT (2) ATE319467T1 (ru)
AU (1) AU2003232248B8 (ru)
CA (1) CA2485389A1 (ru)
DE (2) DE60303940T2 (ru)
DK (2) DK1652520T3 (ru)
ES (2) ES2259144T3 (ru)
HK (1) HK1076033A1 (ru)
IL (2) IL165122A (ru)
IT (1) ITMI20020994A1 (ru)
NO (1) NO332806B1 (ru)
PL (2) PL204549B1 (ru)
PT (2) PT1505997E (ru)
RU (1) RU2313358C2 (ru)
SI (1) SI1652520T1 (ru)
WO (1) WO2003094944A1 (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2478382C2 (ru) * 2007-07-03 2013-04-10 Индена С.П.А. Комбинации вазоактивных веществ с эстрогенами и их применение для лечения сексуальных дисфункций у женщин

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100692174B1 (ko) * 2005-03-25 2007-03-09 손병국 신장활성과 항피로, 강정, 강장, 성기능 개선용 건강기능식품
CN1989990B (zh) * 2005-12-27 2010-09-01 郭凯 一种治疗勃起功能障碍的药物及其制备方法
US9918489B2 (en) * 2008-12-17 2018-03-20 Mark Gorris Food-based supplement delivery system
US20100178413A1 (en) * 2008-12-17 2010-07-15 Mark Gorris Food-based Supplement Delivery System
US20110206788A1 (en) 2010-01-29 2011-08-25 Chaudhary Latha Novel herbal composition
ITRM20100068A1 (it) * 2010-02-19 2011-08-20 Fabrizio Iacono Integratore alimentare con componenti che stimolano la funzione sessuale nel maschio
IT1395768B1 (it) * 2009-09-17 2012-10-19 Iacono Integratore alimentare con componenti che stimolano la funzione sessuale nel maschio
ES2430226T3 (es) * 2009-09-17 2013-11-19 Tradapharma Sagl Suplemento dietético que estimula la función sexual masculina
ES2386859B1 (es) * 2011-02-07 2013-03-22 Eduardo Antonio Gómez De Diego Composición natural para aumentar el vigor.
RU2458537C1 (ru) * 2011-03-14 2012-08-20 Общество С Ограниченной Ответственностью "Парафарм" Биологически активная добавка к пище для профилактики эректильной дисфункции у мужчин
KR20130032419A (ko) * 2011-09-23 2013-04-02 씨제이제일제당 (주) 복합생약추출물을 포함하는 발기부전 예방 및 개선용 조성물
WO2013106647A1 (en) * 2012-01-13 2013-07-18 Dharma Biomedical, Llc Supercritical guggul extracts and uses thereof
RU2496491C1 (ru) 2012-08-20 2013-10-27 Общество С Ограниченной Ответственностью "Парафарм" Способ восстановления полового влечения (либидо) у мужчин путем применения биологически активной добавки к пище для восстановления полового влечения (либидо) у мужчин
TW201420745A (zh) * 2012-11-26 2014-06-01 Tian-De Li 擴充男性海綿體的複方精油
CN103250851A (zh) * 2013-02-24 2013-08-21 沈根林 一种中药补肾蜜饯肠
CN103250852A (zh) * 2013-02-24 2013-08-21 沈根林 一种中药补肾蜜饯肠
CN104000198B (zh) * 2014-06-13 2016-03-23 上海赫尔伯生物科技有限公司 一种具有补肾填精、益神兴阳作用的复方胶囊及其制备方法
CN104352540B (zh) * 2014-10-20 2017-08-18 成都中医药大学 一种治疗冠心病心绞痛的亲水凝胶骨架型缓释片及其制备方法
US20190105274A1 (en) * 2015-07-13 2019-04-11 Kyowa Hakko Bio Co., Ltd. Tablets containing arginine at high concentration
CN106614589A (zh) * 2016-11-13 2017-05-10 徐州得铸生物科技有限公司 一种含蒺藜皂甙的杀虫剂组合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU674602B2 (en) * 1993-09-14 1997-01-02 Hyung Ki Choi Pharmaceutical composition for prophylaxis and treatment of premature ejaculation
FR2765483B1 (fr) * 1997-07-04 2000-02-04 Philippe Gorny Medicament destine a traiter les dysfonctions erectiles
US6007824A (en) * 1998-07-09 1999-12-28 Duckett; Melvin J. Natural composition and method for the treatment of sexual dysfunction
KR100394329B1 (ko) * 1999-06-17 2003-08-09 북경동방백오의약개발유한공사 성기능장애 및 혈관계질환의 치료용 약제학적 조성물
US20020013280A1 (en) * 2000-06-16 2002-01-31 Zhongcheng Xin Pharmaceutical composition for preventing and treating sexual dysfunction and vasculargenic disease comprising icariin
US6702733B1 (en) * 1999-07-01 2004-03-09 40 J's Llc Expanded clitoral sensitizing compounds with methods and apparatus for the delivery of these compounds
KR20010009653A (ko) * 1999-07-12 2001-02-05 유제경 성기능 장애를 위한 치료용 조성물
US20010008638A1 (en) 1999-07-14 2001-07-19 Brian J. Wilding Nutritional supplement comprising at least one prohormone and at least one anti-estrogen compound in a time-release dosage form
US6343258B1 (en) * 1999-08-13 2002-01-29 ALEXIS Brian Method for testing for readiness for harvesting of tribulus terrestris l. having high steroidal saponin content
US6399579B1 (en) * 2000-08-15 2002-06-04 Hauser, Inc. Compositions comprising icariside I and anhydroicaritin and methods for making the same
US6803060B2 (en) * 2000-09-07 2004-10-12 Joe Reyes Composition to boost libido

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2478382C2 (ru) * 2007-07-03 2013-04-10 Индена С.П.А. Комбинации вазоактивных веществ с эстрогенами и их применение для лечения сексуальных дисфункций у женщин

Also Published As

Publication number Publication date
AU2003232248A1 (en) 2003-11-11
EP1505997A1 (en) 2005-02-16
ES2297593T3 (es) 2008-05-01
ITMI20020994A0 (it) 2002-05-10
JP2005530769A (ja) 2005-10-13
JP2011079853A (ja) 2011-04-21
ES2259144T3 (es) 2006-09-16
RU2313358C2 (ru) 2007-12-27
IL165122A (en) 2009-09-22
US7438934B2 (en) 2008-10-21
DE60317946T2 (de) 2008-11-27
EP1652520A3 (en) 2006-05-17
EP1505997B1 (en) 2006-03-08
ITMI20020994A1 (it) 2003-11-10
PL204549B1 (pl) 2010-01-29
HK1076033A1 (en) 2006-01-06
PL205893B1 (pl) 2010-06-30
CA2485389A1 (en) 2003-11-20
US7361370B2 (en) 2008-04-22
US20050175722A1 (en) 2005-08-11
PT1652520E (pt) 2008-01-18
ATE380024T1 (de) 2007-12-15
AU2003232248B8 (en) 2009-07-30
EP1652520B1 (en) 2007-12-05
NO332806B1 (no) 2013-01-14
IL192137A (en) 2012-06-28
DE60317946D1 (de) 2008-01-17
PT1505997E (pt) 2006-07-31
IL192137A0 (en) 2008-12-29
CN1652807A (zh) 2005-08-10
SI1652520T1 (sl) 2008-04-30
KR20040102219A (ko) 2004-12-03
DE60303940D1 (de) 2006-05-04
EP1652520A2 (en) 2006-05-03
IL165122A0 (en) 2005-12-18
AU2003232248B2 (en) 2007-05-31
PL373096A1 (en) 2005-08-08
DE60303940T2 (de) 2006-08-10
US20080145458A1 (en) 2008-06-19
NO20044877L (no) 2004-11-09
DK1652520T3 (da) 2008-04-14
ATE319467T1 (de) 2006-03-15
DK1505997T3 (da) 2006-07-17
CN100522178C (zh) 2009-08-05
WO2003094944A1 (en) 2003-11-20
JP4733385B2 (ja) 2011-07-27

Similar Documents

Publication Publication Date Title
RU2004133025A (ru) Препаративные формы, полезные при лечении мужской и женской импотенции
RU2004132833A (ru) Лекарственные формы, полезные для лечения мужской и женской импотенции
RU2015115064A (ru) Композиции для непрерывного введения ингибиторов допа-декарбоксилазы
FI3782612T3 (fi) Sytidiinianalogien oraalisia formulaatioita ja menetelmiä niiden käyttämiseksi
RU2012125827A (ru) Применение аналога тестостерона и агониста 5-нт1а для лечения сексуальной дисфункции
RS52922B (en) PREPARATIONS FOR THE TREATMENT OF MULTIPLE SCLEROSIS AND THEIR USES
RU2007138582A (ru) Пероральные дозированные формы производных гемцитабина
UA102111C2 (ru) Фармацевтическая композиция в виде разовой пероральной дозы, которая содержит леводопу, карбидопу и энтакапон или их соли
AR030630A1 (es) Composiciones farmaceuticas
HRP20110370T1 (hr) Uporaba agomelatina za dobivanje lijeka u cilju liječenja smith-magenisovog sindroma
AR115994A1 (es) Combinación farmacéutica sinérgica que comprende tramadol clorhidrato y pregabalina, y su uso para el tratamiento del dolor neuropático
EA200500957A1 (ru) Применение l-допа, его производных и лекарственных средств, содержащих эти соединения, для профилактики психотических заболеваний
JP2020100611A (ja) 内服用医薬組成物
ECSP034484A (es) Composiciones farmaceuticas
UY26406A1 (es) Aminoácidos bicíclicos como agentes farmacéuticos

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20150503